×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
GNLX – genelux corporation (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
GNLX
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/28
04:10 pm
gnlx
Genelux Corporation Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
Medium
Report
Genelux Corporation Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
3/25
11:58 am
gnlx
Genelux Co. (NASDAQ: GNLX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $30.00 price target on the stock.
Low
Report
Genelux Co. (NASDAQ: GNLX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $30.00 price target on the stock.
3/25
08:52 am
gnlx
Genelux prices 3M shares at $3.50 in underwritten public offering [Seeking Alpha]
Medium
Report
Genelux prices 3M shares at $3.50 in underwritten public offering [Seeking Alpha]
3/25
08:31 am
gnlx
Genelux Corporation Announces Pricing of $10.5 Million Underwritten Offering of Common Stock
Medium
Report
Genelux Corporation Announces Pricing of $10.5 Million Underwritten Offering of Common Stock
3/25
08:30 am
gnlx
Genelux and Newsoara Announce Positive Preliminary Phase 1b/2 Data of Olvi-Vec in Advanced Small-Cell Lung Cancer
High
Report
Genelux and Newsoara Announce Positive Preliminary Phase 1b/2 Data of Olvi-Vec in Advanced Small-Cell Lung Cancer
3/25
08:30 am
gnlx
Genelux Announces Alignment with FDA on Key Elements of the Approval Pathway for Olvi-Vec in Platinum Resistant/Refractory Disease
High
Report
Genelux Announces Alignment with FDA on Key Elements of the Approval Pathway for Olvi-Vec in Platinum Resistant/Refractory Disease
2/3
06:45 am
gnlx
Genelux Corporation Announces New Chief Financial Officer
Medium
Report
Genelux Corporation Announces New Chief Financial Officer
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
3/28
04:06 pm
gnlx
Form 10-K GENELUX Corp For: Dec 31
Medium
Report
Form 10-K GENELUX Corp For: Dec 31
3/25
05:28 pm
gnlx
Form 8-K GENELUX Corp For: Mar 25
High
Report
Form 8-K GENELUX Corp For: Mar 25
3/25
09:05 am
gnlx
Form FWP GENELUX Corp Filed by: GENELUX Corp
Low
Report
Form FWP GENELUX Corp Filed by: GENELUX Corp
3/25
09:04 am
gnlx
Form 8-K GENELUX Corp For: Mar 25
Low
Report
Form 8-K GENELUX Corp For: Mar 25
2/3
06:17 pm
gnlx
Form 4 GENELUX Corp For: Jan 31 Filed by: Pulisic Matthew
High
Report
Form 4 GENELUX Corp For: Jan 31 Filed by: Pulisic Matthew
2/3
06:16 pm
gnlx
Form 3 GENELUX Corp For: Jan 30 Filed by: Pulisic Matthew
High
Report
Form 3 GENELUX Corp For: Jan 30 Filed by: Pulisic Matthew
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: